Doximity, Inc.
24.19USD
-0.2300 (-0.94%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.35▼ | $0.37 | 2 | 13 |
| Next quarter | $0.42▼ | $0.44 | 3 | 13 |
| Current year | $1.35▼ | $1.43 | 0 | 18 |
| Next year | $1.55▼ | $1.59 | 2 | 11 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.3 | $0.29 | -0.01 (-4.2%) |
| 2026-03-31 | $0.28 | $0.26 | -0.02 (-7.9%) |
| 2025-12-31 | $0.45 | $0.46 | +0.01 (+2.9%) |
| 2025-09-30 | $0.38 | $0.45 | +0.07 (+18.7%) |
200 ratings from 26 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Freedom Capital Markets | Downgraded from Buy | Hold | $24 $27 | Sep 8, 2026 |
| Barclays | Maintained | Equal-Weight | $20 $27 | Aug 21, 2026 |
| Truist Securities | Maintained | Hold | $19 $24 | Aug 13, 2026 |
| Wells Fargo | Downgraded from Equal-Weight | Underweight | $18 | Aug 10, 2026 |
| JP Morgan | Maintained | Neutral | $26 $31 | Aug 7, 2026 |
| Piper Sandler | Reiterated | Overweight | $42 $47 | Aug 7, 2026 |
| Evercore ISI Group | Maintained | In-Line | $22 $40 | Aug 7, 2026 |
| B of A Securities | Downgraded from Buy | Underperform | $38 $20 | Jun 29, 2026 |
| Goldman Sachs | Maintained | Neutral | $28 $24 | May 15, 2026 |
| Barclays | Downgraded from Overweight | Equal-Weight | $38 $20 | May 15, 2026 |
| Leerink Partners | Maintained | Outperform | $31 $25 | May 14, 2026 |
| Jefferies | Downgraded from Buy | Hold | $51 $19 | May 14, 2026 |
| Canaccord Genuity | Maintained | Buy | $34 $30 | May 14, 2026 |
| JP Morgan | Maintained | Neutral | $33 $28 | May 14, 2026 |
| Goldman Sachs | Maintained | Neutral | $28 $24 | May 14, 2026 |
| Truist Securities | Reiterated | Hold | $29 $19 | May 14, 2026 |
| Wells Fargo | Downgraded from Overweight | Equal-Weight | $32 $18 | May 14, 2026 |
| BMO Capital | Maintained | Market Perform | $25 $20 | May 14, 2026 |
| Mizuho | Maintained | Neutral | $34 $26 | May 14, 2026 |
| Morgan Stanley | Maintained | Overweight | $49 $35 | May 14, 2026 |
| BTIG | Downgraded from Buy | Neutral | — | May 14, 2026 |
| Keybanc | Downgraded from Overweight | Sector Weight | — | May 14, 2026 |
| Needham | Maintained | Buy | $55 $27 | May 14, 2026 |
| Baird | Downgraded from Outperform | Neutral | $40 $18 | May 14, 2026 |
| Wells Fargo | Maintained | Overweight | $45 $32 | May 11, 2026 |
128 filings from 14 insiders · 20 buy / 11 sell over 6m
Officers and directors of DOCS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Wampler Kira SchererDirector | ExerciseClass B Common Stock | 2.0k | — | — | Sep 1, 2026 |
| Wampler Kira SchererDirector | ExerciseClass B Common Stock | 2.0k | — | — | Sep 1, 2026 |
| Wampler Kira SchererDirector | ExerciseStock Option (Right to Buy) | 2.0k | — | — | Sep 1, 2026 |
| Wampler Kira SchererDirector | Sell | 2.0k | $26.33 | $53k | Sep 1, 2026 |
| Wampler Kira SchererDirector | Exercise | 2.0k | — | — | Sep 1, 2026 |
| Yang Watkin Phoebe L.Director | Grant | 8.1k | — | — | Aug 27, 2026 |
| Wampler Kira SchererDirector | Grant | 8.1k | — | — | Aug 27, 2026 |
| Cabral Timothy SDirector | Grant | 8.1k | — | — | Aug 27, 2026 |
| Benjamin Regina M.Director | Grant | 8.1k | — | — | Aug 27, 2026 |
| Spain KevinDirector | Grant | 8.1k | — | — | Aug 27, 2026 |
| WAMPLER KIRA SCHERERDirector | Sell | 2.0k | $24.95 | $50k | Aug 25, 2026 |
| WAMPLER KIRA SCHERERDirector | Other | 2.0k | — | — | Aug 25, 2026 |
| SITARAM SIDDHARTHOfficer | Sell | 1.8k | $24.94 | $44k | Aug 13, 2026 |
| SITARAM SIDDHARTHOfficer | Other | 5.0k | — | — | Aug 13, 2026 |
| CABRAL TIMOTHY SDirector | Sell | 7.5k | $27.40 | $206k | Aug 7, 2026 |
| CABRAL TIMOTHY SDirector | Other | 7.5k | — | — | Aug 7, 2026 |
| SITARAM SIDDHARTHOfficer | Sell | 1.7k | $22.02 | $38k | Jul 15, 2026 |
| SITARAM SIDDHARTHOfficer | Other | 4.8k | — | — | Jul 15, 2026 |
| BENJAMIN REGINA M.Director | Grant | 21.3k | — | — | Jul 13, 2026 |
| SITARAM SIDDHARTHOfficer | Sell | 2.4k | $20.41 | $50k | Jun 8, 2026 |
No analyst notes on DOCS yet.
Analyst Ratings
18 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 3 | 11 | 1 | 1 | Hold2.52 |
| 1 mo ago | 5 | 4 | 10 | 1 | 1 | Buy2.48 |
| 2 mo ago | 5 | 4 | 11 | 0 | 1 | Buy2.43 |
| 3 mo ago | 5 | 4 | 12 | 0 | 1 | Buy2.45 |